ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » California » Geriatric Medicine

Top Geriatric Medicine Prescribers in California

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHAEWON SONG MD

Geriatric Medicine

46,582

$2.85M

1238
1194 are 65+

1%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

36%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $52

CHRISTINE ROZANCE M.D.

Geriatric Medicine

46,368

$2,230

240
223 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

40%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 24%

$0
Average prescription price

Avg: $52

NOUNEH DANIELYAN M.D.

Geriatric Medicine

36,735

$3.05M

609
537 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 24%

$83
Average prescription price

Avg: $52

MARCEL FILART MD

Geriatric Medicine

34,786

$1.93M

769
534 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$56
Average prescription price

Avg: $52

SEUNG KIM M.D.

Geriatric Medicine

26,488

$1.98M

842
804 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 14%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 24%

$75
Average prescription price

Avg: $52

WILLIAM WELSH D.O.

Geriatric Medicine

24,659

$1.59M

819
713 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $52

STEPHEN GROSSMAN M.D.

Geriatric Medicine

22,924

$1.1M

782
674 are 65+

16%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 24%

$48
Average prescription price

Avg: $52

MUSHRIK KAISEY MD

Geriatric Medicine

22,401

$1.09M

665
626 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$49
Average prescription price

Avg: $52

SIKANDER KAJANI M.D.

Geriatric Medicine

21,896

$1.02M

698
438 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $52

IRA BRAVERMAN MD

Geriatric Medicine

21,486

$1.22M

678
453 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$57
Average prescription price

Avg: $52

JOY HINKLE MD

Geriatric Medicine

21,059

$1.13M

378
320 are 65+

30%
patients receiving schedule two controlled substances

Avg: 6%

44%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$54
Average prescription price

Avg: $52

AZMY GHALY MEDICAL DOCTOR

Geriatric Medicine

20,786

$968K

564
495 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

18%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 24%

$47
Average prescription price

Avg: $52

DAN TRAN M.D.

Geriatric Medicine

19,381

$1.36M

721
633 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

10%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $52

JACQUELYN VANDER WALL M.D.

Geriatric Medicine

19,138

$961K

781
740 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$50
Average prescription price

Avg: $52

VICTOR SIEW M.D.

Geriatric Medicine

18,486

$1.13M

497
352 are 65+

21%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 24%

$61
Average prescription price

Avg: $52

JOSE LARA M.D.

Geriatric Medicine

17,350

$952K

704
605 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$55
Average prescription price

Avg: $52

INNA YASKIN DO

Geriatric Medicine

16,346

$1.16M

664
581 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

8%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

33%
prescriptions for brand name drugs

Avg: 24%

$71
Average prescription price

Avg: $52

SHEHAB SADDY MD

Geriatric Medicine

15,818

$946K

567
531 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 24%

$60
Average prescription price

Avg: $52

NORMAN CHIEN MD

Geriatric Medicine

15,753

$1.1M

473
451 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 24%

$70
Average prescription price

Avg: $52

DAT DUONG M.D.

Geriatric Medicine

15,672

$1.02M

426
363 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $52

GLENN KISSINGER MD

Geriatric Medicine

15,418

$788K

365
259 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 24%

$51
Average prescription price

Avg: $52

MICHAEL KARAPETIAN M.D.

Geriatric Medicine

14,902

$1.1M

407
364 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

15%
patients receiving schedule three controlled substances

Avg: 14%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 24%

$74
Average prescription price

Avg: $52

PAUL LIU M.D.

Geriatric Medicine

14,861

$963K

423
326 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

9%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 24%

$65
Average prescription price

Avg: $52

SARAH OLELEWE M.D.

Geriatric Medicine

14,673

$1.19M

475
396 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

26%
patients receiving schedule three controlled substances

Avg: 14%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 24%

$81
Average prescription price

Avg: $52

MARY SHERMAN MD

Geriatric Medicine

14,521

$589K

786
781 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 14%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 24%

$41
Average prescription price

Avg: $52

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank